We then characterized a panel of ABT-199-resistantmyeloid leukemia cell lines derived through chronic exposure to ABT-199 and foundthat acquired drug resistance is indeed driven by the upregulation of MCL-1 andBCL-XL. The gene discussed is MCL1; the disease is leukemia.